OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their robustness in expressing complex biologics. Enhancing these processes involves modifying various parameters, including cell line development, media composition, and bioreactor settings. A key goal is to increase antibody titer while minimizing production costs an